Avermectin induced inflammation damage in king pigeon brain

Chemosphere

Volumn 93, Issue 10, 2013, Pages 2528-2534

  Chen, Li Jie ^a,b   Sun, Bao Hong ^a,b   Qu, Jian ping ^a   Xu, Shiwen ^a   Li, Shu ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Avermectin; Brain; Inflammatory damage; King pigeon

Indexed keywords

BRAIN; CELL PROLIFERATION; MITOCHONDRIA;

AVERMECTINS; EXPRESSION LEVELS; FOUR-GROUP; INFLAMMATORY DAMAGES; KING PIGEON; NF-KAPPAB; STRUCTURAL DAMAGES; TOXIC EFFECT;

PATHOLOGY;

AVERMECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E; ANTIPARASITIC AGENT; BIOLOGICAL MARKER; IVERMECTIN; MESSENGER RNA; NOS2 PROTEIN, HUMAN;

BIRD; BRAIN; CHEMICAL COMPOUND; DIET; MITOCHONDRION; NERVOUS SYSTEM; TOXICITY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN DAMAGE; CEREBELLUM; CONTROLLED STUDY; HISTOPATHOLOGY; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTIC LOBE; PIGEON; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; INFLAMMATION; METABOLISM; PHYSIOLOGY; PIGEONS AND DOVES; TOXICITY;

COLUMBA;

ANIMALS; ANTIPARASITIC AGENTS; BIOLOGICAL MARKERS; BRAIN; COLUMBIDAE; INFLAMMATION; IVERMECTIN; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER;

EID: 84886950504     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2013.09.058     Document Type: Article

References (51)

1. Ahmad N., Chen L.C., Gordon M.A., Laskin J.D., Laskin D.L. Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J. Leukoc. Biol. 2002, 71:1005-1011.
2. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14:649-683.
3. Banks C.N., Lein P.J. A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation. Neurotoxicology 2012, 33:575-584.
4. Brown G.C., Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol. Neurobiol. 2003, 27:325-355.
5. Campbell W.C., Fisher M.H., Stapley E.O., Albers-Schonberg G., Jacob T.A. Ivermectin: a potent new antiparasitic agent. Science 1983, 221:823-828.
6. Celik-Ozenci C., Tasatargil A., Tekcan M., Sati L., Gungor E., Isbir M., Demir R. Effects of abamectin exposure on male fertility in rats: potential role of oxidative stress-mediated poly(ADP-ribose) polymerase (PARP) activation. Regul. Toxicol. Pharmacol. 2011, 61:310-317.
7. Davies I.M., McHenery J.G., Rae G.H. Environmental risk from dissolved ivermectin to marine organisms. Aquaculture 1997, 158:263-275.
8. del Zoppo G., Ginis I., Hallenbeck J.M., Iadecola C., Wang X., Feuerstein G.Z. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol. 2000, 10:95-112.
9. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 1998, 12:1063-1073.
10. Erzen N.K., Kolar L., Flajs V.C., Kuzner J., Marc I., Pogacnik M. Degradation of abamectin and doramectin on sheep grazed pasture. Ecotoxicology 2005, 14:627-635.
11. Fu J., Liu C.P., Zhang Z.W., Liao W., Xu S.W. Effects of acute and chronic cold stress on expression of cyclooxygenase-2 and prostaglandin E synthase mrna in quails intestine. Pak. Vet. J. 2012.
12. Halley B.A., VandenHeuvel W.J., Wislocki P.G. Environmental effects of the usage of avermectins in livestock. Vet. Parasitol. 1993, 48:109-125.
13. Hoozemans J.J., O'Banion M.K. The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs. Curr. Drug Targets CNS Neurol. Disord. 2005, 4:307-315.
14. Jencic V., Cerne M., Erzen N.K., Kobal S., Cerkvenik-Flajs V. Abamectin effects on rainbow trout (Oncorhynchus mykiss). Ecotoxicology 2006, 15:249-257.
15. Kaltschmidt B., Uherek M., Wellmann H., Volk B., Kaltschmidt C. Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. Proc. Natl. Acad. Sci. USA 1999, 96:9409-9414.
16. Kaltschmidt B., Widera D., Kaltschmidt C. Signaling via NF-kappaB in the nervous system. Biochim. Biophys. Acta 2005, 1745:287-299.
17. Kang R.Y., Freire-Moar J., Sigal E., Chu C.Q. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br. J. Rheumatol. 1996, 35:711-718.
18. Kim J.S., Crichlow E.C. Clinical signs of ivermectin toxicity and the efficacy of antigabaergic convulsants as antidotes for ivermectin poisoning in epileptic chickens. Vet. Hum. Toxicol. 1995, 37:122-126.
19. Kolar L., Kozuh Erzen N., Hogerwerf L., van Gestel C.A. Toxicity of abamectin and doramectin to soil invertebrates. Environ. Pollut. 2008, 151:182-189.
20. Kolar L., Jemec A., van Gestel C.A., Valant J., Hrzenjak R., Erzen N.K., Zidar P. Toxicity of abamectin to the terrestrial isopod Porcellio scaber (Isopoda, Crustacea). Ecotoxicology 2010, 19:917-927.
21. Kubatka P., Ahlers I., Ahlersova E., Adamekova E., Luk P., Bojkova B., Markova M. Chemoprevention of mammary carcinogenesis in female rats by rofecoxib. Cancer Lett. 2003, 202:131-136.
22. Lankas G.R., Cartwright M.E., Umbenhauer D. P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity. Toxicol. Appl. Pharmacol. 1997, 143:357-365.
23. Lawrence T., Gilroy D.W., Colville-Nash P.R., Willoughby D.A. Possible new role for NF-kappaB in the resolution of inflammation. Nat. Med. 2001, 7:1291-1297.
24. Liu R.H., Hotchkiss J.H. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat. Res. 1995, 339:73-89.
25. Lovell R.A. Ivermectin and piperazine toxicoses in dogs and cats. Vet. Clin. North Am. Small Anim. Pract. 1990, 20:453-468.
26. Lumaret J.P., Errouissi F. Use of anthelmintics in herbivores and evaluation of risks for the non target fauna of pastures. Vet. Res. 2002, 33:547-562.
27. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15:323-350.
28. Makarov S.S. NF-kappaB as a therapeutic target in chronic inflammation: recent advances. Mol. Med. Today 2000, 6:441-448.
29. Manabe Y., Anrather J., Kawano T., Niwa K., Zhou P., Ross M.E., Iadecola C. Prostanoids, not reactive oxygen species, mediate COX-2-dependent neurotoxicity. Ann. Neurol. 2004, 55:668-675.
30. Martin R.J. Modes of action of anthelmintic drugs. Vet. J. 1997, 154:11-34.
31. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
32. Mattson M.P., Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 2001, 107:247-254.
33. McKellar Q.A. Ecotoxicology and residues of anthelmintic compounds. Vet. Parasitol. 1997, 72:413-426. (discussion 426-435).
34. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neurol. 2004, 63:901-910.
35. Molinari G., Soloneski S., Reigosa M.A., Larramendy M.L. In vitro genotoxic and cytotoxic effects of ivermectin and its formulation ivomec on Chinese hamster ovary (CHOK1) cells. J. Hazard. Mater. 2009, 165:1074-1082.
36. Moore J.C., DeRuiter P.C., Hunt H.W. Soil invertebrate/micro-invertebrate interactions: disproportionate effects of species on food web structure and function. Vet. Parasitol. 1993, 48:247-260.
37. Novelli A., Vieira B.H., Cordeiro D., Cappelini L.T., Vieira E.M., Espindola E.L. Lethal effects of abamectin on the aquatic organisms Daphnia similis, Chironomus xanthus and Danio rerio. Chemosphere 2012, 86:36-40.
38. Paul A.J., Tranquilli W.J., Seward R.L., Todd K.S., DiPietro J.A. Clinical observations in collies given ivermectin orally. Am. J. Vet. Res. 1987, 48:684-685.
39. Reali C., Scintu F., Pillai R., Donato R., Michetti F., Sogos V. S100b counteracts effects of the neurotoxicant trimethyltin on astrocytes and microglia. J. Neurosci. Res. 2005, 81:677-686.
40. Renard P., Raes M. The proinflammatory transcription factor NFkappaB: a potential target for novel therapeutical strategies. Cell Biol. Toxicol. 1999, 15:341-344.
41. Suarez V.H. Helminthic control on grazing ruminants and environmental risks in South America. Vet. Res. 2002, 33:563-573.
42. Sun Y., Diao X., Zhang Q., Shen J. Bioaccumulation and elimination of avermectin B1a in the earthworms (Eisenia fetida). Chemosphere 2005, 60:699-704.
43. Sun Y.J., Long D.X., Li W., Hou W.Y., Wu Y.J., Shen J.Z. Effects of avermectins on neurite outgrowth in differentiating mouse neuroblastoma N2a cells. Toxicol. Lett. 2010, 192:206-211.
44. Tisler T., Kozuh Erzen N. Abamectin in the aquatic environment. Ecotoxicology 2006, 15:495-502.
45. Tschopp J. Mitochondria: Sovereign of inflammation?. Eur. J. Immunol. 2011, 41:1196-1202.
46. Tunctan B., Uludag O., Altug S., Abacioglu N. Effects of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice. Pharmacol. Res. 1998, 38:405-411.
47. Wang T., Pei Z., Zhang W., Liu B., Langenbach R., Lee C., Wilson B., Reece J.M., Miller D.S., Hong J.S. MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration. FASEB J. 2005, 19:1134-1136.
48. Wislocki P.G., Grosso L.S., Dybas R.A. Environmental aspects of abamectin use in crop protection. Ivermectin and Abamectin 1989, 185-200. Springer Verlag, New York. W.C. Campbell (Ed.).
49. Yang D., Elner S.G., Bian Z.M., Till G.O., Petty H.R., Elner V.M. Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells. Exp. Eye Res. 2007, 85:462-472.
50. Yao H.D., Qiong W., Zhang Z.W., Shu L., Wang X.L., Xu S.W., Lei X.G. Selenoprotein W serves as an antioxidant in chicken myoblasts. Biochim. Biophys. Acta 2013, 1830:3112-3120.
51. Yokoyama H., Kuroiwa H., Yano R., Araki T. Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease. Neurol. Sci. 2008, 29:293-301.